HEALTH chiefs need to double the number of neurologists to give patients with illnesses of the brain and nervous system a fair shot at a good quality of life.

A MULTIPLE SCLEROSIS drug pulled from the US market last year is to return and has also been given preliminary approval for use in Europe, a move that will be welcomed by the 6,000 Irish people affected by the condition.

EVERY year, 250 Irish people get news that some greet with dismay, others with relief, because, as they say themselves, “at least I know now that I am not going crazy.”